Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
René Schade is listed as Director of Epidemiology (Global) at CSL Behring, based in Germany, Germany, Germany. AeroLeads shows a matched LinkedIn profile for René Schade.
René Schade previously worked as Director Epidemiology (Global) • QCSR • Strategic Development at Csl Behring and Senior Principal of Epidemiology • Global RWE Strategy & Analytics / Global HEORE at Icon Plc. René Schade holds Master'S Degree, Epidemiology from Erasmus University Rotterdam.
This section adds company-level context without repeating René Schade's masked contact details.
Review company-level records connected to René Schade before choosing the right outreach path.
MD, MSc Epidemiology with 18+ Postgraduate Years in Real-World Evidence | Pharmacoepidemiology | Comparative Effectiveness & Safety | Regulatory/HTA Impact | Medical Informatics (RWD) | Big-Data Epidemiology & Advanced Analytics | Global RWD Landscaping/Mapping | Training & CoachingEffective and agile leader, communicator, and team player. Competent in making innovative solutions a reality, including scale-up. Brings out the best in people. Strategist and systems thinker with strong business acumen.Generalist with wealth of experience in oncology, haematology, immunology, neurology and cardiovascular.13+ Years in highly collaborative, multi-country RWE projects, including the following federated RWD networks:-- HONEUR Haematological Outcomes Network in Europe (Janssen, J&J)-- CVD-Real Study across 6 countries (AstraZeneca)-- SOS Project (5 countries, 35 million patients from 7 databases)1500+ Citations (2200+ on Google Scholar) of original research articles, mainly longitudinal RWE studies of comparative effectiveness/safety (high risk). Publications/slides: https://www.researchgate.net/profile/Rene_Schade24+ Years in clinical medicine and/or health sciences. First pharmaceutical job 21+ years ago in Global Pharmacovigilance.Interested in: -- Team building & people development-- Strategy, business development, process improvement-- Integrated value/evidence/access strategies-- External (real world) control arms & Bias analysis-- PASS/PAES-- Federated data networks (FDNs), common data models-- Precision medicine-- Data science, NLP, predictive analytics/ machine learningExtensive experience in design & delivery of RWE projects for drug development & lifecycle management with top-tier (mainly longitudinal) US, UK, EU, and Asian healthcare databases:Gained traction 18+ years ago as Principal Investigator who made innovative use of UK's CPRD (Schade et al., NEJM 2007). More recently, worked with the likes of JMDC & MDV (Japan), NCRAS (UK), Flatiron (US), Optum (US), Diabetes Collaborative Registry (US), GePaRD (Germany), Lombardy Regional Database (Italy), CPRD/ THIN & HES (UK), IPCI & PHARMO (NL), and the Nordic registries (Scandinavia).Advanced: SAS and SQL. Basic: R and PythonFluent in English, Dutch, German (native), and Spanish.Please don't hesitate to write me a message. For specific responsibilities in current and past roles, please see texts in Experience sections and publications below. Endorsements/recommendations have always been disabled for this profile
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Melbourne, Victoria, AU
Global Epidemiology & RWD/RWE Product Lead (Haematology, Cardiovascular & Renal, and Immunoglobulines) for:-- Hemgenix (world's first gene therapy for hemophilia B, approved Nov 2022 by FDA & Feb 2023 by EMA)-- Apolipoportein A-I (recurrent MI/MACE; CSL's largest trial to date, AEGIS-II, topline Q1 2024)-- Indication extension for immunoglobulin Hizentra.
Dublin, IE
People leader: 6-12 direct reports and ~30 global staff as matrix group director. Global functional scope. The group is part of ICON Commercial Solutions/ Commercialisation & OutcomesCoordinating & coaching an international team of (mostly senior) epidemiologists, pharmacoepidemiologists, statisticians, data scientists, health economists, and systematic.
Cambridge, Cambridgeshire, GB
Global RWE Informatics/Analytics. Matrix Manager. Global Cardiovascular-Metabolic/Diabetes Health Informatics TA Lead. Oncology Support. Co-lead in multi-database epidemiology projects: Real-world insight using US Optum-Humedica and the US Diabetes Collaborative Registry; Critical appraisal of RWE study protocols; cross-functional knowledge integration &.
Rotterdam, Zuid-Holland, NL
Pharmacoepidemiology Unit, Departments of Medical Informatics & Epidemiology:Teaching of advanced epidemiological methods (both, internal at department and external at paid-for courses at major international conferences)Study design/end-to-end project delivery (lead or co-lead) of longitudinal, comparative safety studies (patient-level EHR & claims data.
Montreal, Qc, CA
McGill Pharmacoepidemiology Research Unit (Division of Clinical Epidemiology,Royal Victoria Hospital). Research Fellowship (paid). Real world, comparative drug safety research
Montreal, Qc, CA
Department of Epidemiology & Biostatistics:MSc Program (1-Year Full-Time Graduate Student with Exams)
Berlin, DE
2008 Clinical Resident (MD) in Neurology, Charité, Humboldt University (full-time employment)2005-2007 Pharmacoepidemiology Scientist (Project Lead), Charité Institute of Clinical Pharmacology and Toxicology (full-time employment):-- Project Lead; design & conduct (end-to-end) of longitudinal RWE comparative-safety database studies with CPRD (EHR's of >6.
Berlin, DE
Humboldt University of Berlin, Medical Degree, German State Medical Licence(Vollapprobation als Arzt). Student.Minimum standard program duration: 6 years and 3 months (equivalent BSc + MSc)Selected Internships (Speciality Choices: Neurology & Immunology), Training Awards and Extracurricular Activities: - UCL, London, Institute of Neurology & National.
Berlin, Berlin-Brandenburg, DE
Global Pharmacovigilance, Schering AG Pharmaceuticals (now: Bayer). Part-time employmentFocus on multiple sclerosis (interferon beta/ Betaferon/Betaseron)Post-marketing drug safety; observational-data analytics (internal database); ADR case report assessment; periodic safety update reports (PSURs) for regulators
Berlin, DE
Full-time employment as part of civilian service (choice of military service), 15 months
Quick answers generated from the profile data available on this page.
René Schade works for CSL Behring.
René Schade is listed as Director of Epidemiology (Global) at CSL Behring.
René Schade is based in Germany, Germany, Germany while working with CSL Behring.
René Schade has worked for Csl Behring, Icon Plc, Phastar, Astrazeneca, and Erasmus Mc.
You can use AeroLeads to view verified contact signals for René Schade at CSL Behring, including work email, phone, and LinkedIn data when available.
René Schade holds Master'S Degree, Epidemiology from Erasmus University Rotterdam.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts